By Sierra Jackson ( January 29, 2021, 6:02 PM EST) -- Rare disease-focused Catabasis Pharmaceuticals said Friday it landed roughly $110 million in a private investment in public equity, or PIPE, deal led by life sciences investor Perceptive Advisors after buying a biopharmaceutical company, with guidance from three law firms....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.